Recent News

Dismissal in Medtronic Inversion Litigation Reversed on Appeal; Komlossy Law Among Counsel

March 4th, 2016|0 Comments

Komlossy Law, P.A. is one of the three counsel that had the dismissal of the Medtronic shareholder litigation reversed and remanded in late January.

Medtronic’s $43 […]

Ross Worked With BeverageTradeNetwork on a Recent Article about Craft Beer Label Design and Requirements

June 9th, 2014|0 Comments

Please click on the following link on BeverageTradeNetwork to read the recent article in which Ross was consulted regarding craft beer label design. The article discusses the process and requirements […]

Dismissal in Medtronic Inversion Litigation Reversed on Appeal; Komlossy Law Among Counsel

March 4th, 2016|0 Comments

Komlossy Law, P.A. is one of the three counsel that had the dismissal of the Medtronic shareholder […]

Beer Bill Passes Unanimously

April 24th, 2015|4 Comments

The Senate’s malt beverages bill that includes the legalization of the 64 ounce growler passed […]

Growler Bill Closer to Reality (with a bit of a catch)

April 1st, 2015|0 Comments

On Wednesday, a proposed amendment to CS/SB 186 was filed that would place an artificial […]

Investigation of proposed sale of Hyperion Therapeutics, Inc. (HPTX) to Horizon Pharma plc (HZNP)

March 31st, 2015|0 Comments

Komlossy Law, P.A. is investigating the Board of Directors of Hyperion Therapeutics, Inc. (“Hyperion” or the […]

Recent Blog Posts

Beer Bill Passes Unanimously

April 24th, 2015|4 Comments

The Senate’s malt beverages bill that includes the legalization of the 64 ounce growler passed the House today with a unanimous vote. Much of the news has focused on the excitement of the new found freedom of the […]

Growler Bill Closer to Reality (with a bit of a catch)

April 1st, 2015|0 Comments

On Wednesday, a proposed amendment to CS/SB 186 was filed that would place an artificial cap on the number of vendor licenses that a brewery in Florida may obtain.  There is currently no such limit but the amendment […]

Where We Are With 2015 Malt Beverage Legislation

March 27th, 2015|0 Comments

I have been asked a few times in recent days for a quick update of where things generally stand as we near the halfway point in the 2015 legislative session.  This is that:

Senate Bill 186, filed by Senator […]

Current Investigations

Komlossy Law, P.A. is investigating the Board of Directors of Hyperion Therapeutics, Inc. (“Hyperion” or the “Company”) (NASDAQ: HPTX) for possible breaches of fiduciary duty and other violations of state law in connection with their attempt to complete a sale of the Company to Horizon Pharma plc (“Horizon”).  Pursuant to the terms of the proposed transaction, Hyperion shareholders are to receive $46.00 for each share of the Company. This represents only a 7.6% premium based on Hyperion’s March 27, 2015 closing price. The proposed compensation is also well below recent price targets set by industry analysts.

The investigation involves whether the Board of Directors of Hyperion breached its fiduciary duties to stockholders by failing to adequately shop the Company before agreeing to enter into the transaction, and whether the transaction is fair to shareholders with respect to price, process and disclosure of all material information.

If you own Hyperion stock and wish to obtain additional information about your rights as a shareholder, or if you have information about the above investigation, please contact Emily C. Komlossy or Ross Appel via email at eck@komlossylaw.com or raa@komlossylaw.com, respectively, or by telephone toll free at (855) 858-1233.  More information is available at http://komlossylaw.com/hyperion/.

Komlossy Law, P.A. is investigating the Board of Directors of Norcraft Companies, Inc. (“Norcraft” or the “Company”) (NYSE: NCFT) for possible breaches of fiduciary duty and other violations of state law in connection with their attempt to complete a sale of the Company to Fortune Brands Home & Security, Inc. (“Fortune”).  Pursuant to the terms of the proposed transaction, Norcraft shareholders are to receive $25.50 for each share of the Company they own. This represents only an 11.4% premium based on Norcraft’s March 27, 2015 closing price.

The investigation involves whether the Board of Directors of Norcraft breached its fiduciary duties to stockholders by failing to adequately shop the Company before agreeing to enter into the transaction, and whether the transaction is fair to shareholders with respect to price, process and disclosure of all material information.

If you own Norcraft stock and wish to obtain additional information about your rights as a shareholder, or if you have information about the above investigation, please contact Emily C. Komlossy, Esq. via email at eck@komlossylaw.com or by telephone toll free at (855) 858-1233.

Komlossy Law, P.A. is investigating the Board of Directors of SFX Entertainment, Inc. (“SFX” or the “Company”) (NASDAQ: SFXE) for possible breaches of fiduciary duty and other violations of state law in connection with a proposal from Robert F.X. Sillerman, the Company’s Chief Executive Officer and Executive Chairman of the Board of Directors, to acquire all of the outstanding shares of common stock of the company not already owned by him for $4.75 per share in cash. Sillerman owns nearly 40% of the outstanding common stock of SFX Entertainment.

The investigation relates to whether the proposal is fair to the public stockholders of SFX and whether Sillerman is seeking to take advantage of his insider knowledge with respect to the going private proposal. SFX has traded above the offer price for a large majority of its history as a public company.

If you own SFX stock and wish to obtain additional information about your rights as a shareholder at not cost, or if you have information about the above investigation, please contact Emily C. Komlossy, Esq. via email at eck@komlossylaw.com or by telephone toll free at (855) 858-1233.

Komlossy Law, P.A. is investigating the Board of Directors of Emulex Corporation (“Emulex” or the “Company”) (NYSE: ELX) for possible breaches of fiduciary duty and other violations of state law in connection with their attempt to complete a sale of the Company to Avago Technologies Limited (“Avago”).  Pursuant to the terms of the proposed transaction, Emulex shareholders are to receive $8.00 for each share of the Company.

The investigation involves whether the Board of Directors of Emulex breached its fiduciary duties to stockholders by failing to adequately shop the Company before agreeing to enter into the transaction, and whether the transaction is fair to shareholders with respect to price, process and disclosure of all material information.

If you own Emulex stock and wish to obtain additional information about your rights as a shareholder, or if you have information about the above investigation, please contact Emily C. Komlossy, Esq. via email at eck@komlossylaw.com or by telephone toll free at (855) 858-1233.

Komlossy Law, P.A. represents shareholders in complex litigation, including class action and derivative litigation.  Komlossy Law, P.A. may co-counsel with another firm, or refer a case to another firm.  More information is available upon request.

 

Register for Newsletter

Email info@komlossylaw.com to sign up for our newsletter (Subject: Subscribe).

NewsLetter2Cover